Impairment of the in vitro release of carbamazepine from tablets

Bosnian Journal of Basic Medical Sciences

Volumn 10, Issue 3, 2010, Pages 234-238

  Uzunović, Alija ^a   Vranić, Edina ^b   Hadžidedić, Šeherzada ^a  

^a Agency for Medical Products and Medical Devices of Bosnia and Herzegovina   (Bosnia and Herzegovina)

^b UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Carbamazepine; Impairment; In vitro release

Indexed keywords

EID: 77957160748     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2010.2693     Document Type: Article

References (15)

1. Sweetman S.C. Martindale: The complete drug reference. 34th ed. Pharmaceutical Press, London, 2005.
2. Rinaki E., Valsami, G., and Macheras, P. Quantitative biopharma-ceutics classification system: Se central role of dose/solubility ratio. Pharm. Res. 2003; 20:1917-1925
3. Lobenberg R, Amidon GL. Modern bioavailability, bioequiva-lence and biopharmaceutics classification system: new scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 2000;50:3-12.
4. Desai K.G.H., Kulakarni A.R., Aminbhavi T.M. Solubility of Rofecoxib in presence of methanol, ethanol and sodium lauryl sulphate at (298.15, 303.15 and 308.15) K. J. Chem. Eng. Data. 2003;48: 942-945.
5. Rawat S., Jain S.K. Rofecoxib-cyclodextrin inclusion complex for solubility enhancement. Pharmazie 2003;58:639-641.
6. Moneghini M., Voinovich D., Perissutti B., Princivalle F. Action of carriers on carbamazepine dissolution. Pharm. Dev. Technol. 2002;7:289-296.
7. Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin. Pharmacokinet. 1978;3:128-143.
8. Lake O.A., Olling M., Barends D.M. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers. Eur. J. Pharm. Biopharm. 1999; 48:9-13
9. Zerrouk N., Chemtob C., Arnaud P., Toscani S., Dugue J. In vitro and in vivo evaluation of carbamazepine-PFG 6000 solid dispersions. Int. J. Pharm. 2001; 225:49-62
10. Moneghini M., Kikic I., Voinovich D., Perissutti B., Filipovic Grcic J. Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: Preparation, characterization, and in vitro dissolution. Int. J. Pharm. 2001;222:129-138
11. Sarkari M., Brown J., Chen X., Swinnea S., Williams III R.O., Johnston KP. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm. 2002; 243:17-31
12. Sethia S., Squilante E. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. J. Pharm. Sci. 2002; 91:1948-1957
13. Perissutti B., Rubessa F., Moneghini M., Voinovich D. Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique. Int. J. Pharm. 2003; 256: 53-63
14. Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000; 50:47-60
15. Ribardiere A., Tchoreoff P., Couarraze G., Puisieux F. Modification of ketoprofen bead structure produced by the spherical crystallization technique with a two-solvent system. Int. J. Pharm. 1996; 144:195-207